Creades AB

Established in 2011 and headquartered in Stockholm, Sweden, Creades AB operates as an investment entity focused on both private equity and venture capital. The firm's mandate is broad, covering the entire lifecycle of companies from nascent seed and startup stages, through various venture capital rounds (early, mid, late), to supporting emerging growth businesses, middle-market entities, growth capital initiatives, and buyout transactions. Creades specifically targets small and medium-sized enterprises, whether publicly traded or privately held, with an exclusive geographical focus on Swedish companies. When investing, Creades typically allocates sums ranging from SEK 100 million to SEK 300 million (equivalent to approximately $15.51 million to $46.53 million). The firm often seeks to acquire a majority ownership stake and a seat on the board of directors within its investee companies. These investments are financed using the firm's own capital resources and balance sheet.

Creades AB trades as CRED-A.ST on STO. The company is classified in Financial Services / Asset Management and reports in SEK.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Creades AB can be compared against peers such as CoinShares International Limited, Hoist Finance AB (publ), Karnell Group AB ser. B, MedCap AB (publ), Investment AB Öresund (publ), Ratos AB (publ).

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $10.19B, beta of 1.10, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CRED-A.ST currently shows total debt of N/A and beta of 1.10. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.creades.se

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.